<!DOCTYPE html>
<!--[if IE 9]><html lang="en-US" class="no-js ie-9"> <![endif]-->
<!--[if gt IE 9]><!--> <html lang="en-US" class="no-js"><!--<![endif]-->
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<title>Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer | Class Dismissed</title>
<meta name="description" itemprop="description" content>
<meta name="description" itemprop="keywords" content>
<link rel="canonical" href="https://classdismissed.mofo.com/topics/supreme-court-decides-prescription-drug-preemption-case-in-favor-of-drug-manufacturer_01.html">
<link rel="stylesheet" id="validate-engine-css-css" href="css/blog-validationEngine.jquery.css" type="text/css" media="all">
<link rel="stylesheet" id="fontello-css" href="css/blog-embedded.css" type="text/css" media="all">
<link rel="stylesheet" id="mofo-fonts-css" href="css/blog-fonts.css" type="text/css" media="all">
<link rel="stylesheet" id="child-normalize-css" href="css/blog-normalize.css" type="text/css" media="all">
<link rel="stylesheet" id="child-foundation-css" href="css/blog-foundation.css" type="text/css" media="all">
<link rel="stylesheet" id="child-style-css" href="css/blog-style.css" type="text/css" media="all">
<link rel="stylesheet" id="child-jetpack-css" href="css/blog-jetpack.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-custom-style.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-print.css" type="text/css" media="all">
<link rel="stylesheet" href="css/blog-simple-nav.css" type="text/css" media="all">
<link rel="shortcut icon" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png" type="image/icon">
<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="favicon.ico">
<link rel="icon" href="favicon.ico" type="image/icon">
<link rel="apple-touch-icon" type="image/png" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone -->
<link rel="apple-touch-icon" type="image/png" sizes="72x72" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPad -->
<link rel="apple-touch-icon" type="image/png" sizes="114x114" href="https://media2.mofo.com/designimages/mofo-favicon-blue-180x180-2018.png"><!-- iPhone4 -->
<link rel="stylesheet" href="css/jquery-ui.css">


    <!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-T8Z9VLF');</script>
    <!-- End Google Tag Manager -->


<script defer src="js/all.js" crossorigin="anonymous"></script>

<!-- Jetpack Open Graph Tags -->
<meta property="og:type" content="website">
<meta property="og:title" content="Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer">


																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																															<meta property="og:description" content="The+United+States+Supreme+Court+finally+clarified+its+11-year-old+%26ldquo%3Bclear+evidence%26rdquo%3B+standard+for+pharmaceutical+preemption.++In+its+much-anticipated+opinion+delivered+by+Justice+Breyer%2C+the+Court+unanimously+reversed+the+Third+Circuit%26rsquo%3Bs+holding+that+questions+of+pharmaceutical+preemption+should+be+decided+by+juries.++Merck">
<meta property="og:url" content="https://classdismissed.mofo.com/topics/supreme-court-decides-prescription-drug-preemption-case-in-favor-of-drug-manufacturer_01.html">
<meta property="og:site_name" content="Class Dismissed">
<meta property="og:image" content="%24string.replaceAll%28%24!content.image.url%2C%20%27http_%27%2C" https:")">
<meta property="og:locale" content="en_US">



<style>
.svg-inline--fa {

    /*height: .8em;*/

    }
.svg-inline--fa {
    width: .475em;
}
 .sd-content a.nc-facebook-circled{
     color: #3b5998;
     font-size: 30px;
     }
     .sd-content a.nc-linkedin-circled{
     color: #0077b5;
     font-size: 30px;
     }
     .sd-content a.nc-twitter-circled{
     color: #00acee;
     font-size: 30px;
     }
     .sd-content a.nc-fa-envelope-square{
     color: #034193 ;
     font-size: 30px;
     }  
     .sd-content a.nc-fa-print{
     color: #000 ;
     font-size: 30px;
     }                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
     .sd-content a hover {
     }
     .sd-content i {
      margin: -4px;
     }
     #searchsubmit {
      font-size: 1em;
      border-radius: 3px;
      font-family: 'Oswald';
      text-transform: uppercase;
      letter-spacing: 2px;
      border-style: solid;
      border-width: 0;
      font-weight: 500;
    }
</style>

<meta name="google-site-verification" content="OD6S3RPM-cQOknAs1uXmBRvRJyh28rwkOoqdes47ZUE">
</head>
<body class="single single-post postid-572426032 single-format-standard full-width custom-background-empty">
    <!-- Google Tag Manager (noscript) -->
    <noscript>
      <iframe src="https://www.googletagmanager.com/ns.html?id=GTM-T8Z9VLF" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <!-- End Google Tag Manager (noscript) -->
    <script type="text/javascript"> 
<!-- 
var bb=new Image();var _ti=910;var _q="";var na=(navigator.appName=="Netscape");var ns=(navigator.appName.substring(0,9)=="Microsoft");var _qDate=new Date();var _r=(document.referrer.indexOf(getdomain(location))>-1?"":document.referrer);_q+="&5="+parseInt(_qDate.getTimezoneOffset());_q+="&35="+parseInt(_qDate.toString().indexOf("aylight")>-1?1:0);_q+="&6=572426032";_q+="&7=3335911";_q+="&8="+encodeURIComponent(document.location);_q+="&9="+encodeURIComponent(_r);_q+="&10="+encodeURIComponent(document.title);_q+="&11="+encodeURIComponent(navigator.userAgent);_q+="&12="+encodeURIComponent((na?navigator.language:navigator.userLanguage));_q+="&13="+((navigator.javaEnabled()?'1':'0'));if(document.cookie.indexOf("cc")==-1)document.cookie="cc=t;";_q+="&15="+((document.cookie.indexOf("cc")==-1)?"0":"1");_q+="&16="+encodeURIComponent((screen.width+'x'+screen.height));_q+="&17="+encodeURIComponent(((ns)?screen.colorDepth:screen.pixelDepth));_q+="&18="+encodeURIComponent(Math.random());_q+="&19="+_ti;bb.src="https://s.clickability.com/s?"+_q;
function setonclicks(a,b){var i=0;var retval=true;while(document.links[i]!=a){i++;}if(b.li[i])retval=b.li[i].oldonclick();bye(a);return retval;}
function newonld(){if(hasonload)oldonld();lnks=new Object();var sze=document.links.length;lnks.li=new Array(sze);for (var i=0; i<sze; i++){if(document.links[i].onclick){lnks.li[i]=document.links[i];lnks.li[i].oldonclick=document.links[i].onclick;}eval("document.links[i].onclick=function(){return setonclicks(this,lnks);}");}}function bye(a){if(a.href.toLowerCase().indexOf('http')!=0)return true;if(getdomain(location)==getdomain(a))return true;if(a.href.toLowerCase().indexOf('http')!=0)return true;var _qc="https://s.clickability.com/s?19=912";_qc+="&6=572426032";_qc+="&7=3335911";_qc+="&18="+encodeURIComponent(Math.random());_qc+="&100="+a.href;_qc+="&101="+encodeURIComponent(a.text);var cc=new Image();if(na){cc.src=_qc;pc(100);}else cc.src=_qc;return true;}function pc(a){d = new Date(); while (1){m =new Date(); df = m-d;if( df > a ) {break;}}}function getdomain(a){var i=a.host.indexOf(":");return (i>=0)?a.host.substring(0,i):a.host;}if(self['setupalready']){var dosetup = false;alert('There are two $imware.tracker calls on this page. Please alert Client Services');}else{var dosetup = true;var hasonload=false;}if(dosetup && ((window.screen)||((new Array()).toSource)||((new Array()).shift&&ns))&&(navigator.userAgent.indexOf('Mac')<0)){if(window.onload){oldonld=window.onload;hasonload=true;}window.onload=newonld;var setupalready = true;}//-->
</script><noscript>
<img alt="Clickability tracking pixel" width="1" height="1" src="https://s.clickability.com/s?19=990&amp;14=0&amp;6=572426032&amp;7=3335911&amp;25=0&amp;18=0.20629552023087505">
</noscript>

<div class="main-body-container" data-equalizer>    
<div class="nav_container">
	<a class="skip-link screen-reader-text" href="#content">Skip to content</a>  
        <div class="nav_wrap row ">
        	<div> <!-- add sticky here if needed -->
        	  <div>
                    <nav class="top-bar" data-topbar data-options="scrolltop:false;mobile_show_parent_link:false;">                  
                        <ul class="title-area">
	                        <li class="mofo-logo">
			                    <a href="https://www.mofo.com" title="Morrison & Foerster" target="_blank">
						<img src="https://media2.mofo.com/images/morrison-foerster-blog-logo.png" alt="logo">
			                    </a>
			                </li>
                            <li class="name">
                                <div class="header-title">
                                	<a href="index.html" title="Class Dismissed" rel="home">
                                	                                	Class Dismissed
                                	                                	</a>
                                </div>
                                                                <div class="header-subtitle">
                               		<span class="pms-7702c">Class Action and Product Insights for Your Business
                                </span></div>
                                                            </li>							
                            <!-- Remove the class "menu-icon" to get rid of menu icon. Take out "Menu" to just have icon alone -->
                                                    </ul>
</nav>
</div><!-- contain-to-grid sticky -->                
</div><!-- .row -->
</div>        
</div>
<!-- end .nav_container -->  


<div class="topnav" id="myTopnav">

<a href="index.html">Home</a>



<div class="divider"></div>
<div class="dropdown">

    <button class="dropbtn active">Topics 
     <i class="fa fa-caret-down"></i>
    </button>
    <div class="dropdown-content">

	
		 	<a href="topics_4.html">ADA</a>
		 	<a href="topics_21.html">Announcements & Press</a>
		 	<a href="topics_1.html">Antitrust</a>
		 	<a href="topics_3.html">Appellate & Supreme Court</a>
		 	<a href="topics.html">Arbitration</a>
		 	<a href="topics_31.html">Autonomous Vehicles & Robotics</a>
		 	<a href="topics_18.html">Aviation & Drones</a>
		 	<a href="topics_11.html">CPSC</a>
		 	<a href="topics_8.html">Class Action</a>
		 	<a href="topics_32.html">Class Certification</a>
		 	<a href="topics_14.html">Consumer Products</a>
		 	<a href="topics_33.html">Coronavirus (COVID-19)</a>
		 	<a href="topics_16.html">Drug & Medical Device</a>
		 	<a href="topics_10.html">Emergency Use Authorization (EUA)</a>
		 	<a href="topics_29.html">Environmental Law</a>
		 	<a href="topics_13.html">FAA</a>
		 	<a href="topics_15.html">FCRA</a>
		 	<a href="topics_6.html">FDA</a>
		 	<a href="topics_28.html">FTC</a>
		 	<a href="topics_19.html">False Advertising</a>
		 	<a href="topics_2.html">Food Misbranding</a>
		 	<a href="topics_25.html">Government Actions</a>
		 	<a href="topics_24.html">Internet of Things</a>
		 	<a href="topics_27.html">MDL</a>
		 	<a href="topics_5.html">Mass Torts</a>
		 	<a href="topics_30.html">NAD</a>
		 	<a href="topics_23.html">Pharmaceutical & Medical Devices</a>
		 	<a href="topics_12.html">Privacy</a>
		 	<a href="topics_26.html">Product Liability</a>
		 	<a href="topics_9.html">Public Readiness and Emergency Preparedness Act (PREP Act)</a>
		 	<a href="topics_7.html">Retail</a>
		 	<a href="topics_22.html">TCPA</a>
		 	<a href="topics_17.html">Trials</a>
    </div>
  </div> 


<div class="divider"></div>
<a href="editors.html" class>Editors</a>


<div class="divider"></div>
<a href="about.html" class>About</a>


<div class="divider"></div>
<a href="javascript:void(0);" onclick="openSubscribeModal()" class>Subscribe</a>




<a href="javascript:void(0);" style="font-size:15px;" class="icon" onclick="myFunction()">&#9776;</a>
</div>
    
    
    


<script>
function printPage() {
  window.print();
}
</script>



<div class="content_container">
    <section class="content_wrap row" role="document">
        <div id="content" class="medium-8 large-8 columns" role="main">
            <article id="post-572426032" class="post-572426032 post type-post status-publish format-standard has-post-thumbnail hentry category-foreign-corrupt-practices-act">
                <header class="entry-header">
                    <div class="row blog-header">
                        <div class="columns medium-7 rockwell pms-7702c">
                            <em>June 5, 2019</em>
                            - <a href="topics_3.html" rel="category tag">Appellate & Supreme Court</a>, <a href="topics_6.html" rel="category tag">FDA</a>, <a href="topics_23.html" rel="category tag">Pharmaceutical & Medical Devices</a>, <a href="topics_26.html" rel="category tag">Product Liability</a>
                        </div>
                        <div class="columns medium-5 social-jet">
                            <div class="sharedaddy sd-sharing-enabled">
                                <div class="robots-nocontent sd-block sd-social sd-social-icon sd-sharing">
                                    <h3 class="sd-title">Share This</h3>
                                            <div class="sd-content">
                                                <a title="Share on Facebook" class="nc-facebook-circled" href="unsupportedbrowser.html" target="_blank" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow">
                                                    <i class="fab fa-facebook-square"></i>
                                                                                                    </a>
                                                <a href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://classdismissed.mofo.com/topics/supreme-court-decides-prescription-drug-preemption-case-in-favor-of-drug-manufacturer_01.html&amp;title=Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer&amp;summary=The United States Supreme Court finally clarified its 11-year-old clear evidence standard for pharmaceutical preemption.  In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuits holding that questions of pharmaceutical preemption should be decided by juries.  Merck&amp;source=LinkedIn" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" class="nc-linkedin-circled" target="_blank" title="Share on LinkedIn">
                                                    <i class="fab fa-linkedin"></i>
                                                                                                    </a>
                                                <a href="share_227.html" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" target="_blank" class="nc-twitter-circled" title="Share on Twitter">
                                                    <i class="fab fa-twitter-square"></i>
                                                                                                    </a>
                                                <a href="mailto:recipient@domain.com?subject=Class Dismissed&amp;body=Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer - https://classdismissed.mofo.com/topics/supreme-court-decides-prescription-drug-preemption-case-in-favor-of-drug-manufacturer_01.html" rel="nofollow" class="nc-fa-envelope-square" title="Email this page">
                                                  <i class="fas fa-envelope-square"></i>
                                                </a>
                                                <a href="#" onclick="printPage()" rel="nofollow" class="nc-fa-print" title="Print this page">
                                                  <i class="fas fa-print"></i>
                                                </a>
                                            </div>
                                </div>
                            </div>
                        </div>
                    </div>
                    <h1 class="entry-title">
                        Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer</h1>
                </header>
                <!-- .entry-header -->
                <div class="entry-meta">
                    <div class="blog-author-meta subheader">			
                                                

                                                By: <a href="https://www.mofo.com/people/erin-bosman.html" target="new">Erin M. Bosman</a> and <a href="https://www.mofo.com/people/julie-park.html" target="new">Julie Y. Park</a>
                                                                    </div>
                </div>
                <div class="entry-content">
                                        <p>The United States Supreme Court finally clarified its 11-year-old &ldquo;clear evidence&rdquo; standard for pharmaceutical preemption.&nbsp; In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuit&rsquo;s holding that questions of pharmaceutical preemption should be decided by juries.&nbsp; <em>Merck Sharp &amp; Dohme Corp. v. Albrecht et al.</em>, No. 17-290, slip op. (U.S. May 20, 2019) (&ldquo;<em>Albrecht</em>&rdquo;).&nbsp; However, those who had criticized the Third Circuit&rsquo;s opinion were left wanting more&mdash;the limited holding does not reach the issue of whether plaintiffs&rsquo; claims against the manufacturer were preempted.</p>
<p><b>Background</b></p>
<p>Over 500 patients sued Merck alleging they suffered atypical femoral fractures, a rare type of stress fracture affecting the thigh bone, after using Merck&rsquo;s Fosamax drug.&nbsp; They claimed that Merck failed to disclose these risks on the drug label.&nbsp; Merck countered that FDA had rejected or would have rejected its proposed addition to the drug label.&nbsp; As a result, Merck said it could not comply with both federal drug labeling requirements and its duty to warn under state law.&nbsp; In these circumstances, Merck argued, the federal law and regulations preempt the patients&rsquo; state‑law claims such that Merck should not be held liable for failing to disclose the stress fracture risks to consumers.</p>
<p>Merck based its argument on years of back-and-forth discussions with FDA about whether Fosamax could cause these types of stress fractures.&nbsp; In 1995, when FDA first approved Fosamax, the label did not include the fracture warning because&mdash;at that time&mdash;the risk was still theoretical.&nbsp; After more than a decade of post-market surveillance, Merck sought preapproval to add these risks to its Fosamax label in 2008.&nbsp; FDA rejected Merck&rsquo;s proposed change.&nbsp; Not until 2011 did FDA agree to add language to the Fosamax label disclosing the risks of atypical femoral fractures.</p>
<p>Beginning in 2010, hundreds of patients filed lawsuits that were eventually consolidated in a multidistrict litigation in the District of New Jersey.&nbsp; The district court granted Merck&rsquo;s summary judgment motion on the ground that the patients&rsquo; state-law failure to warn claims were preempted by federal law.&nbsp; The Third Circuit reversed, finding that the preemption question involved factual disputes the jury should have resolved and that Merck needed more evidence to meet the &ldquo;clear evidence&rdquo; standard set forth in <em>Wyeth v. Levine </em>to establish its preemption defense.</p>
<p><b>Defining <em>Wyeth</em>&rsquo;s &ldquo;Clear Evidence&rdquo; Standard</b></p>
<p>In 2009, the Supreme Court issued the first of several important pharmaceutical preemption decisions in <em>Wyeth v. Levine</em>, 555 U.S. 555 (2009).&nbsp; There, a Vermont jury found that Wyeth failed to provide an adequate warning that direct injection of its Phenergan drug created a significant risk of harm to patients.&nbsp; The Vermont Supreme Court agreed, finding no preemption.</p>
<p>The U.S. Supreme Court affirmed.&nbsp; In doing so, the Court explained that unless a drug manufacturer can show &ldquo;clear evidence&rdquo; that FDA would not have approved a change to its drug label, a court cannot conclude that it was impossible for the drug manufacturer to comply with both federal drug labeling requirements and state-law duty to warn requirements.&nbsp; In other words, to succeed on this type of impossibility preemption defense, a drug manufacturer has to provide clear evidence that FDA considered the risk and made an affirmative decision to either (a) not change the label or (b) prohibit the manufacturer from strengthening its warning.</p>
<p>However, what constituted &ldquo;clear evidence&rdquo; under <em>Wyeth </em>remained unclear until now.&nbsp; Post-<em>Wyeth</em>, courts have struggled to apply the undefined clear evidence standard to determine if the FDA would have rejected a proposed warning change that was never submitted.</p>
<p>In <em>Albrecht</em>, Merck had sought preapproval from FDA to strengthen Fosamax&rsquo;s warnings, but that proposal was rejected.&nbsp; When Fosamax users brought state-law failure-to-warn claims, Merck argued that the claims were preempted by federal law because the FDA had rejected Merck&rsquo;s proposed changes to the Fosamax label.</p>
<p>The Court clarified that &ldquo;clear evidence&rdquo; means &ldquo;evidence that shows the court that the drug manufacturer fully informed the FDA of the justifications for the warning required by state law and that the FDA, in turn, informed the drug manufacturer that the FDA would not approve a change to the drug&rsquo;s label to include that warning.&rdquo;&nbsp; This definition dispels the notion that the &ldquo;clear evidence&rdquo; standard is an evidentiary standard, as some district courts had interpreted it to be.</p>
<p>But whether the FDA&rsquo;s action in <em>Albrecht</em> satisfies the standard is left open.&nbsp; The Court did not actually reach the preemption question.</p>
<p><b>Preemption Questions Must Be Decided by the Judge</b></p>
<p>Next, the Court held that judges, not juries, must decide the question of whether state-law failure-to-warn claims are preempted by the Federal Food, Drug, and Cosmetic Act and related labeling regulations.&nbsp; This includes whether there is clear evidence that FDA would not have approved the warning that state law requires.&nbsp; The Court reasoned that resolving questions of agency disapproval often requires legal skills to understand an agency decision within the applicable regulatory framework.&nbsp; The Court acknowledged that the preemption issue typically involves factual disputes but that these factual questions are &ldquo;subsumed within an already tightly circumscribed legal analysis.&rdquo;</p>
<p><b>Key Takeaways</b></p>
<ul>
<li>Justice Thomas joined the opinion but wrote separately to say that Merck&rsquo;s preemption defense failed. Why?&nbsp; Because Merck relied on FDA response letters as evidence that Merck could not have strengthened its warning.&nbsp; According to Justice Thomas, an FDA response letter cannot have preemptive effect because it is &ldquo;not a final agency action with the force of law.&rdquo; &nbsp;His concurrence is surprising given that he wrote the majority opinion in <em>PLIVA, Inc. v. Mensing</em>, 131 S. Ct. 2567 (2011), holding that certain generic pharmaceutical failure-to-warn claims are preempted.</li>
<li>Justice Alito, joined by Justices Roberts and Kavanaugh, also wrote separately. He would have found preemption here and suggested that the Third Circuit should find &ldquo;clear evidence&rdquo; that the FDA would not have approved Merck&rsquo;s label.&nbsp; Justice Alito cited the record showing that FDA was deeply involved in the stress fracture issue for years, and that the agency has a statutory duty to require label changes upon learning new evidence warranting a change. &nbsp;Under these circumstances, Justices Alito, Roberts, and Kavanaugh would have found preemption.</li>
<li>Defendants should welcome this clarity on the &ldquo;clear evidence&rdquo; standard, which relieves them of the confusing pseudo-evidentiary burden that some lower courts had applied.</li>
<li>Although the opinion may disappoint by not reaching the preemption question, Justice Alito&rsquo;s concurrence provides drug manufacturers a roadmap for satisfying the &ldquo;clear evidence&rdquo; standard.</li>
<li>Given the favorable&mdash;albeit limited&mdash;holding, defendants should feel emboldened to assert a federal preemption defense in other areas beyond pharmaceuticals.</li>
</ul>
                        <div class="sharedaddy sd-sharing-enabled">
                            <div class="robots-nocontent sd-block sd-social sd-social-icon sd-sharing">
                                <h3 class="sd-title">Share This</h3>
                                        <div class="sd-content">
                                                <a title="Share on Facebook" class="nc-facebook-circled" href="unsupportedbrowser.html" target="_blank" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow">
                                                    <i class="fab fa-facebook-square"></i>
                                                                                                    </a>
                                                <a href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https://classdismissed.mofo.com/topics/supreme-court-decides-prescription-drug-preemption-case-in-favor-of-drug-manufacturer_01.html&amp;title=Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer&amp;summary=The United States Supreme Court finally clarified its 11-year-old clear evidence standard for pharmaceutical preemption.  In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuits holding that questions of pharmaceutical preemption should be decided by juries.  Merck&amp;source=LinkedIn" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" class="nc-linkedin-circled" target="_blank" title="Share on LinkedIn">
                                                    <i class="fab fa-linkedin"></i>
                                                                                                    </a>
                                                <a href="share_227.html" onclick="javascript:window.open(this.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=350,width=600');return false;" rel="nofollow" target="_blank" class="nc-twitter-circled" title="Share on Twitter">
                                                    <i class="fab fa-twitter-square"></i>
                                                                                                    </a>
                                                <a href="mailto:recipient@domain.com?subject=Class Dismissed&amp;body=Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer - https://classdismissed.mofo.com/topics/supreme-court-decides-prescription-drug-preemption-case-in-favor-of-drug-manufacturer_01.html" rel="nofollow" class="nc-fa-envelope-square" title="Email this page">
                                                  <i class="fas fa-envelope-square"></i>
                                                </a>
                                                <a href="#" onclick="printPage()" rel="nofollow" class="nc-fa-print" title="Print this page">
                                                  <i class="fas fa-print"></i>
                                                </a>
                                        
                                        </div>
                            </div>
                        </div>
                        <!-- .entry-content -->
                        <footer class="entry-meta">
                            <div class="entry-meta-footer">
                            </div>
                            <!-- end .entry-meta-footer -->
                        </footer>
                        <!-- .entry-meta -->
</div></article>
<!-- #post -->
                </div>
                <!-- #content -->
                <div id="secondary" class="medium-4 large-4 columns widget-area data-equalizer-watch" role="complementary">
                                        

        
  

                                                                                                                                                                                                                                                           
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																					                        	                                      
<div class="text-center">
    <img src="https://media2.mofo.com/images/bosman_erin_blog_150x150.png" alt>
</div>
<h5 class="text-center">Erin M. Bosman</h5>
<div class="rockwell text-center subheader">
    Partner
</div>






<p class="bio">Erin Bosman is co-chair of MoFo&rsquo;s Class Actions and Mass Torts Practice Group and is a founder and co-head of the Artificial Intelligence Group. Clients value her business strategy, seeking her comprehensive counsel throughout the product life cycle, especially in high-stakes litigation and product recalls.

Erin's clients value her litigation acumen, retaining her as national coordinating and trial counsel in class action cases and multijurisdictional<a href="https://www.mofo.com/people/erin-bosman.html" target="_blank"> More &rsaquo;</a>


</p>


        
  

                                                                                                                                                                                                                                                           
																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																								                        	                                      
<div class="text-center">
    <img src="https://media2.mofo.com/images/park_julie_blog_150x150.png" alt>
</div>
<h5 class="text-center">Julie Y. Park</h5>
<div class="rockwell text-center subheader">
    Partner
</div>






<p class="bio">Julie protects her clients&rsquo; products throughout the product life cycle. Drawing on her deep technical and legal experience, she counsels clients on consumer product safety regulation and pharmaceutical and medical device preemption. She manages complex and multijurisdictional litigation both in state and federal court and also guides clients through product recalls.

Clients appreciate Julie&rsquo;s ability to assess both the practical business implications and legal impact<a href="https://www.mofo.com/people/julie-park.html" target="_blank"> More &rsaquo;</a>


</p>




<aside id="black-studio-tinymce-3" class="widget widget_black_studio_tinymce">
    <div class="textwidget">
        <div class="gray-sidebar">
            <h5>Stay Connected </h5>
                                        <a title="Connect via LinkedIn" class="nc-linkedin-circled" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via Twitter" class="nc-twitter-circled" href="https://twitter.com/MoFoClassAction" target="_blank">
                        <i class="icon-twitter-circled footer-icons black85"></i>
                    </a>
                                        <a title="Connect via RSS" class="nc-rss" href="http://feeds.feedburner.com/mofo/classdismissed" target="_blank">
                        <i class="icon-rss footer-icons black85"></i>
                    </a>
                            </div>
    </div>
</aside>
<aside id="search-2" class="widget widget_search">
    <form role="search" method="get" id="searchform" action="/search/">
        <div class="row collapse">
            <div class="medium-12 large-12 columns">
                <input type="text" value name="s" id="s">
                    <div class="search-icon">
                        <i class="icon-search footer-icons pms-7702c"></i>
                    </div>
                    <input type="submit" id="searchsubmit" value="Search" class="search-btn">
                    </div>
</div>
</form>
</aside>
<aside id="categories-2" class="widget widget_categories">
    <h6 class="widget-title">Topics</h6>
            <label class="screen-reader-text" for="cat">Topics</label>
            <select name="cat" id="cat" class="postform">
                <option value="-1">Topics</option>
                                                                                                                                                <option class="level-0" value="1463911">ADA</option>
                                                                                                <option class="level-0" value="1463921">Announcements & Press</option>
                                                                                                <option class="level-0" value="1467211">Antitrust</option>
                                                                                                <option class="level-0" value="1467221">Appellate & Supreme Court</option>
                                                                                                <option class="level-0" value="1463931">Arbitration</option>
                                                                                                <option class="level-0" value="1463941">Autonomous Vehicles & Robotics</option>
                                                                                                <option class="level-0" value="1463951">Aviation & Drones</option>
                                                                                                <option class="level-0" value="1463961">CPSC</option>
                                                                                                <option class="level-0" value="1462891">Class Action</option>
                                                                                                <option class="level-0" value="1463971">Class Certification</option>
                                                                                                <option class="level-0" value="1463981">Consumer Products</option>
                                                                                                <option class="level-0" value="1463991">Coronavirus (COVID-19)</option>
                                                                                                <option class="level-0" value="1464001">Drug & Medical Device</option>
                                                                                                <option class="level-0" value="1464011">Emergency Use Authorization (EUA)</option>
                                                                                                <option class="level-0" value="1464021">Environmental Law</option>
                                                                                                <option class="level-0" value="1464031">FAA</option>
                                                                                                <option class="level-0" value="1464041">FCRA</option>
                                                                                                <option class="level-0" value="1464051">FDA</option>
                                                                                                <option class="level-0" value="1464061">FTC</option>
                                                                                                <option class="level-0" value="1464071">False Advertising</option>
                                                                                                <option class="level-0" value="1464081">Food Misbranding</option>
                                                                                                <option class="level-0" value="1464091">Government Actions</option>
                                                                                                <option class="level-0" value="1464101">Internet of Things</option>
                                                                                                <option class="level-0" value="1464111">MDL</option>
                                                                                                <option class="level-0" value="1464121">Mass Torts</option>
                                                                                                <option class="level-0" value="1464131">NAD</option>
                                                                                                <option class="level-0" value="1464141">Pharmaceutical & Medical Devices</option>
                                                                                                <option class="level-0" value="1464151">Privacy</option>
                                                                                                <option class="level-0" value="1464161">Product Liability</option>
                                                                                                <option class="level-0" value="1464451">Public Readiness and Emergency Preparedness Act (PREP Act)</option>
                                                                                                <option class="level-0" value="1464171">Retail</option>
                                                                                                <option class="level-0" value="1464181">TCPA</option>
                                                                                                <option class="level-0" value="1464191">Trials</option>
                                                            </select>
            <script type="text/javascript">
                /* <![CDATA[ */
                (function() {
                var dropdown = document.getElementById( "cat" );
                function onCatChange() {
                if ( dropdown.options[ dropdown.selectedIndex ].value > 0 ) {
                location.href = "/topics/?c=" + dropdown.options[ dropdown.selectedIndex ].value;
                }
                }
                dropdown.onchange = onCatChange;
                })();
                /* ]]> */
            </script>
</aside>
<aside class="widget widget_recent_entries">
    <h6 class="widget-title">Recent Posts</h6>
            <ul>
                                                    <li>
                        <a href="Choose-Your-Forum-Wisely-Supreme-Court-Rejects-No-Harm-No-Foul-Approach-to-Arbitration-Waiver-Analysis.html">Choose Your Forum Wisely: Supreme Court Rejects “No Harm, No Foul” Approach to Arbitration Waiver Analysis</a>
                    </li>
                                                                    <li>
                        <a href="Confidentiality-at-Risk-California-Legislature-Considers-Bill-That-Would-Limit-Scope-of-Confidentiality-in-Product-Liability-and-Environmental-Cases-and-Settlements.html">Confidentiality at Risk: California Legislature Considers Bill That Would Limit Scope of Confidentiality in Product Liability and Environmental Cases and Settlements</a>
                    </li>
                                                                    <li>
                        <a href="2022-Class-Action-Law-Forum-Recap-Insights-Article.html">2022 Class Action Law Forum: Recap & Insights</a>
                    </li>
                                                                    <li>
                        <a href="The-Praxis-of-Faxes-Circuits-Split-on-the-Meaning-of-Advertisement-Under-the-TCPA.html">The Praxis of Faxes: Circuits Split on the Meaning of “Advertisement” Under the TCPA</a>
                    </li>
                                                                    <li>
                        <a href="TCPA-Litigation-Review-and-Update.html">TCPA Litigation Review and Update</a>
                    </li>
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            </ul>
</aside>
<aside id="black-studio-tinymce-6" class="widget widget_black_studio_tinymce">
     <style>

address {
  font-style: normal;
  margin-bottom: 14px;
  margin-left: 10px;
}

address .contact  {
  display: block;
  
}

address .email a:hover {
  color: #0078a0;
}

.location, .attorney, .email {
  display: block;

}

address .email a {
color: #5e5f61;
}

.location {
  font-weight: 900;
  font-family: 'Oswald', sans-serif;
  text-transform: uppercase;
}

.contact-title {
  font-family: 'Oswald', sans-serif;
  font-size: .825em;
  background-color: #eeeeee;
  padding: .8em;
  letter-spacing: 2px;
  text-transform: uppercase;
  margin-bottom: 10px;
  display: block;
  font-weight: 900;
}

</style>




</aside>
                </div>
                <!-- #secondary -->
</section>
<!-- end .content-wrap -->
        </div>
        <!-- end .content_container -->
        <div style="display:none;" id="dialog-message" title="Email Disclaimer">
	
</div>
<div class="footer_container">
    <footer class="footer_wrap row" role="contentinfo">
        <div id="footer" class="row" role="contentinfo">
            <div class="columns medium-12 footer-nav-wrapper">
                <div class="footer-nav">
                    <ul>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-terms-of-use">
                            <a target="_blank" href="https://www.mofo.com/about/terms-notices.html">Terms of Use</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-privacy-policy">
                            <a target="_blank" href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-disclaimer">
                            <a target="_blank" href="https://www.mofo.com/special-content/blog-disclaimer/">Disclaimer</a>
                        </li>
                                                <li class="divider"></li>
                        <li id="menu-item-3395" class="menu-item menu-item-footer menu-item-attorney-advertising">
                            <a target="_blank" href="https://www.mofo.com/about/attorney-advertising.html">Attorney Advertising</a>
                        </li>
                        </ul></div>
                </div>
                <div class="columns medium-12 text-center">
                    <p class="copyright">&copy;1996-2022 Morrison &amp; Foerster LLP. <span class="show-for-small"><br></span>All Rights Reserved.</p>
                </div>
                <div class="medium-2 medium-centered columns">
                                                            <a title="Connect via LinkedIn" class="nc-linkedin" href="https://www.linkedin.com/company/morrison-&amp;-foerster-llp" target="_blank">
                        <i class="icon-linkedin-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via Twitter" class="nc-twitter" href="https://twitter.com/MoFoClassAction" target="_blank">
                        <i class="icon-twitter-circled footer-icons pms-7702c"></i>
                    </a>
                                                            <a title="Connect via RSS" class="nc-rss" href="http://feeds.feedburner.com/mofo/classdismissed" target="_blank">
                        <i class="icon-rss footer-icons pms-7702c"></i>
                    </a>
                                    </div>
                                            </div>
</footer>
<!-- .row -->
</div>
<!-- end #footer_container -->
<div id="backtotop" class="hvr-fade">
    <span class="genericon genericon-collapse"></span>
</div>
<!-- #backtotop -->

</div>
     <div class="textwidget">
        <div id="subscribe-modal" class="reveal-modal" data-reveal aria-labelledby="subscribe-modal" aria-hidden="true" role="dialog">
            <aside class="widget widget_black_studio_tinymce">
                <div class="textwidget newsletter_subscribe">
                    <div>
                        <h5>Subscribe</h5>
                                <p>Never miss a post from Class Dismissed. Enter your email below to stay up-to-date.</p>
                    </div>
                </div>
                            </aside>
            <p>
                <div class="resultLabel"></div>
                <div class="widget_wysija_cont shortcode_wysija newsletter_subscribe">
                                   <iframe src="https://www2.mofo.com/l/323401/2020-10-06/66hjd" width="100%" height="450" type="text/html" frameborder="0" allowTransparency="true" style="border: 0"></iframe>
                                                </div>
                    <a class="close-reveal-modal" onClick="closeSubscriptionModal()" aria-label="Close"></a>
</p></div>
</div>



<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
  ga('create', 'UA-12456654-6', 'auto');   ga('send', 'pageview');
</script>

<script type="text/javascript"> 
/*<![CDATA[*/ 
(function() { 
var sz = document.createElement('script'); sz.type = 'text/javascript'; sz.async = true; 
sz.src = '//siteimproveanalytics.com/js/siteanalyze_59840.js'; 
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(sz, s); 
})(); 
/*]]>*/ 
</script>




<script>
  function myFunction() {
    var x = document.getElementById("myTopnav");
    if (x.className === "topnav") {
      x.className += " responsive";
    } else {
      x.className = "topnav";
    }
  }
  </script>
  
  
  <script>
  

function openSubscribeModal() {
console.log('openSubscribeModal')
  var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'visible';
  m.style.display = 'block';
  }
  
  function closeSubscriptionModal() {
    var m = document.getElementById('subscribe-modal');
  m.style.visibility = 'hidden';
  m.style.display = 'none';
  }

  </script>
  

</body>
</html>